Correction: COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.

Wang, Quan Qiu; Kaelber, David C; Xu, Rong; Volkow, Nora D

Wang, Quan Qiu; Kaelber, David C; Xu, Rong; Volkow, Nora D.

Wang QQ; Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Kaelber DC; Departments of Internal Medicine and Pediatrics and the Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, OH, USA.
Xu R; Center for Artificial Intelligence in Drug Discovery, School of Medicine, Case Western Reserve University, Cleveland, OH, USA. rxx@case.edu.
Volkow ND; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA. nvolkow@nida.nih.gov.

Mol Psychiatry ; 26(1): 40, 2021 Jan.

Article in English | MEDLINE | ID: covidwho-807371

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: Mol Psychiatry Journal subject: Molecular Biology / Psychiatry Year: 2021 Document Type: Article Affiliation country: S41380-020-00895-0

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google